References
- Addington D, Addington J, Maticka-Tyndale E. 1993. Assessing depression in schizophrenia: the calgary depression scale. Br J Psychiatry. 163(S22):39–44. doi:https://doi.org/10.1192/S0007125000292581
- Ahmad S, Hussain S, Akhtar F, Shah FS. 2018. Urdu translation and validation of PHQ-9, a reliable identification, severity and treatment outcome tool for depression. J Pak Med Assoc. 68(8):1166–1170.
- Ahmad S, Hussain S, Shah FS, Akhtar F. 2017. Urdu translation and validation of GAD-7: a screening and rating tool for anxiety symptoms in primary health care. J Pak Med Assoc. 67(10):1536–1540.
- American Psychiatric Association. 2000. Diagnostic and Statistical Manual of Mental Disorders DSM-IV-TR. Virginia: APA.
- Asher L, Patel V, De Silva MJ. 2017. Community-based psychosocial interventions for people with schizophrenia in low and middle-income countries: systematic review and meta-analysis. BMC Psychiatry. 17(1):355. doi:https://doi.org/10.1186/s12888-017-1516-7
- Attkisson CC, Zwick R. 1982. The client satisfaction questionnaire. Psychometric properties and correlations with service utilization and psychotherapy outcome. Eval Program Plann. 5(3):233–237. doi:https://doi.org/10.1016/0149-7189(82)90074-X
- Barrowclough C, Tarrier N. 1992. Families of schizophrenic patients: cognitive behavioural intervention. London: Chapman & Hall.
- Beusenberg M, Orley JH. 1994. A User's guide to the self reporting questionnaire (SRQ). Geneva: World Health Organisation.
- Bird V, Premkumar P, Kendall T, Whittington C, Mitchell J, Kuipers E. 2010. Early intervention services, cognitive-behavioural therapy and family intervention in early psychosis: systematic review. Br J Psychiatry. 197(5):350–356. doi:https://doi.org/10.1192/bjp.bp.109.074526
- Broadbent E, Petrie KJ, Main J, Weinman J. 2006. The brief illness perception questionnaire. J Psychosom Res. 60(6):631–637. doi:https://doi.org/10.1016/j.jpsychores.2005.10.020
- Chakrabarti S. 2011. Family interventions in schizophrenia: issues of relevance for Asian countries. World J Psychiatry. 1(1):4–7. doi:https://doi.org/10.5498/wjp.v1.i1.4
- Charlson FJ, Ferrari AJ, Santomauro DF, Diminic S, Stockings E, Scott JG, McGrath JJ, Whiteford HA. 2018. Global epidemiology and burden of schizophrenia: findings from the Global Burden of Disease Study 2016. Schizophr Bull. 44(6):1195–1203. doi:https://doi.org/10.1093/schbul/sby058
- Chaudhry IB, Hallak J, Husain N, Minhas F, Stirling J, Richardson P, Dursun S, Dunn G, Deakin B. 2012. Minocycline benefits negative symptoms in early schizophrenia: a randomised double-blind placebo-controlled clinical trial in patients on standard treatment. J Psychopharmacol. 26(9):1185–1193. doi:https://doi.org/10.1177/0269881112444941
- Chaudhry IB, Husain N, Ur Rahman R, Husain MO, Hamirani MM, Kazmi A, Baig S, Haddad PM, Buch MH, Qureshi I, et al. 2015. A randomised double-blind placebo-controlled 12- week feasibility trial of methotrexate added to treatment as usual in early schizophrenia: study protocol for a randomised controlled trial. Trials. 16:9. doi:https://doi.org/10.1186/1745-6215-16-9
- Claxton M, Onwumere J, Fornells-Ambrojo M. 2017. Do family interventions improve outcomes in early psychosis? A systematic review and meta-analysis. Front Psychol. 8:371. doi:https://doi.org/10.3389/fpsyg.2017.00371
- Cooper CL, Whitehead A, Pottrill E, Julious SA, Walters SJ. 2018. Are pilot trials useful for predicting randomisation and attrition rates in definitive studies: a review of publicly funded trials. Clin Trials. 15(2):189–196. doi:https://doi.org/10.1177/1740774517752113
- David A, Buchanan A, Reed A, Almeida O. 1992. The assessment of insight in psychosis. Br J Psychiatry. 161:599–602. doi:https://doi.org/10.1192/bjp.161.5.599
- De Silva MJ, Cooper S, Li HL, Lund C, Patel V. 2013. Effect of psychosocial interventions on social functioning in depression and schizophrenia: meta-analysis. Br J Psychiatry. 202(4):253–260. doi:https://doi.org/10.1192/bjp.bp.112.118018
- Degnan A, Baker S, Edge D, Nottidge W, Noke M, Press CJ, Husain N, Rathod S, Drake RJ. 2018. The nature and efficacy of culturally-adapted psychosocial interventions for schizophrenia: a systematic review and meta-analysis. Psychol Med. 48(5):714–727. doi:https://doi.org/10.1017/S0033291717002264
- Eldridge SM, Chan CL, Campbell MJ, Bond CM, Hopewell S, Thabane L, Lancaster GA. 2016. CONSORT 2010 statement: extension to randomised pilot and feasibility trials. Pilot Feasibility Stud. 2:64. doi:https://doi.org/10.1186/s40814-016-0105-8
- Emsley R, Chiliza B, Asmal L, Harvey BH. 2013. The nature of relapse in schizophrenia. BMC Psychiatry. 13:50. doi:https://doi.org/10.1186/1471-244X-13-50
- Endicott J, Spitzer RL, Fleiss JL, Cohen J. 1976. The global assessment scale. A procedure for measuring overall severity of psychiatric disturbance. Arch Gen Psychiatry. 33(6):766–771. doi:https://doi.org/10.1001/archpsyc.1976.01770060086012
- Global Burden of Disease Study. 2015. Global, regional, and national incidence, prevalence, and years lived with disability for 301 acute and chronic diseases and injuries in 188 countries, 1990–2013: a systematic analysis for the Global Burden of Disease Study 2013. Lancet. 386(9995):743–800. doi:https://doi.org/10.1016/S0140-6736(15)60692-4
- Griner D, Smith TB. 2006. Culturally adapted mental health intervention: a meta-analytic review. Psychotherapy. 43(4):531–548. doi:https://doi.org/10.1037/0033-3204.43.4.531
- Herth K. 1991. Development and refinement of an instrument to measure hope. Sch Inq Nurs Pract. 5(1):39–51; Discussion 3–6.
- Husain MI, Chaudhry IB, Rahman RR, Hamirani MM, Mehmood N, Haddad PM, Hodsoll J, Young AH, Naeem F, Husain N, et al. 2017a. Pilot study of a culturally adapted psychoeducation (CaPE) intervention for bipolar disorder in Pakistan. Int J Bipolar Disord. 5(1):3. doi:https://doi.org/10.1186/s40345-017-0074-8
- Husain MO, Chaudhry IB, Mehmood N, Rehman RU, Kazmi A, Hamirani M, Kiran T, Bukhsh A, Bassett P, Husain MI, et al. 2017b. Pilot randomised controlled trial of culturally adapted cognitive behavior therapy for psychosis (CaCBTp) in Pakistan. BMC Health Serv Res. 17(1):808. doi:https://doi.org/10.1186/s12913-017-2740-z
- Husain MO, Zehra SS, Umer M, Kiran T, Husain M, Soomro M, Dunne R, Sultan S, Chaudhry IB, Naeem F, et al. 2020. Stigma towards mental and physical illness: attitudes of healthcare professionals, healthcare students and the general public in Pakistan. BJPsych Open. 6(5):e81. in presss. doi:https://doi.org/10.1192/bjo.2020.66
- Jaaskelainen E, Juola P, Hirvonen N, McGrath JJ, Saha S, Isohanni M, Veijola J, Miettunen J. 2013. A systematic review and meta-analysis of recovery in schizophrenia. Schizophr Bull. 39(6):1296–1306. doi:https://doi.org/10.1093/schbul/sbs130
- Jamison DT, Gelband H, Horton S, Jha P, Laxminarayan R, Mock CN, et al. 2017. Improving health and reducing poverty. 3rd ed. Washington D.C.: World Bank.
- Jones SH, Thornicroft G, Coffey M, Dunn G. 1995. A brief mental health outcome scale-reliability and validity of the Global Assessment of Functioning (GAF). Br J Psychiatry. 166(5):654–659. doi:https://doi.org/10.1192/bjp.166.5.654
- Julious SA. 2005. Sample size of 12 per group rule of thumb for a pilot study. Pharmaceut Statist. 4(4):287–291. doi:https://doi.org/10.1002/pst.185
- Kay SR, Fiszbein A, Opler LA. 1987. The positive and negative syndrome scale (PANSS) for schizophrenia. Schizophr Bull. 13(2):261–276. doi:https://doi.org/10.1093/schbul/13.2.261
- Kreyenbuhl J, Buchanan RW, Dickerson FB, Dixon LB. 2010. Schizophrenia patient outcomes research T. The schizophrenia Patient Outcomes Research Team (PORT): updated treatment recommendations 2009. Schizophr Bull. 36(1):94–103. doi:https://doi.org/10.1093/schbul/sbp130
- Kulhara P, Avasthi A, Verma S. 1997. Schizophrenia: The Indian Scene. Mumbai: Searle (India) Limited.
- Lauber C, Rossler W. 2007. Stigma towards people with mental illness in developing countries in Asia. Int Rev Psychiatry. 19(2):157–178. doi:https://doi.org/10.1080/09540260701278903
- Leucht S, Tardy M, Komossa K, Heres S, Kissling W, Salanti G, Davis JM. 2012. Antipsychotic drugs versus placebo for relapse prevention in schizophrenia: a systematic review and meta-analysis. Lancet. 379(9831):2063–2071. doi:https://doi.org/10.1016/S0140-6736(12)60239-6
- Lowe B, Kroenke K, Herzog W, Grafe K. 2004. Measuring depression outcome with a brief self-report instrument: sensitivity to change of the Patient Health Questionnaire (PHQ-9. J Affect Disord. 81(1):61–66. doi:https://doi.org/10.1016/S0165-0327(03)00198-8
- Lozano R, Naghavi M, Foreman K, Lim S, Shibuya K, Aboyans V, Abraham J, Adair T, Aggarwal R, Ahn SY, et al. 2012. Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet. 380(9859):2095–2128. doi:https://doi.org/10.1016/S0140-6736(12)61728-0
- Naeem F, Saeed S, Irfan M, Kiran T, Mehmood N, Gul M, Munshi T, Ahmad S, Kazmi A, Husain N, et al. 2015. Brief culturally adapted CBT for psychosis (CaCBTp): a randomized controlled trial from a low income country. Schizophr Res. 164(1–3):143–148. doi:https://doi.org/10.1016/j.schres.2015.02.015
- Naeem F, Waheed W, Gobbi M, Ayub M, Kingdon D. 2011. Preliminary evaluation of culturally sensitive CBT for depression in Pakistan: findings from Developing Culturally-sensitive CBT Project (DCCP). Behav Cogn Psychother. 39(2):165–173. doi:https://doi.org/10.1017/S1352465810000822
- Nasr T, Kausar R. 2009. Psychoeducation and the family burden in schizophrenia: a randomized controlled trial. Ann Gen Psychiatry. 8:17. doi:https://doi.org/10.1186/1744-859X-8-17
- NICE. 2014. Psychosis and schizophrenia in adults: treatment and management. London: NICE.
- Patel V. 2007. Mental health in low- and middle-income countries. Br Med Bull. 81–82(1):81–96. doi:https://doi.org/10.1093/bmb/ldm010
- Patel V. 2016. Universal health coverage for schizophrenia: a global mental health priority. Schizophr Bull. 42(4):885–890. doi:https://doi.org/10.1093/schbul/sbv107
- Patel V, Maj M, Flisher AJ, De Silva MJ, Koschorke M, Prince M. 2010. Reducing the treatment gap for mental disorders: a WPA survey. World Psychiatry. 9(3):169–176. doi:https://doi.org/10.1002/j.2051-5545.2010.tb00305.x
- Pharoah F, Mari J, Rathbone J, Wong W. 2010. Family intervention for schizophrenia. Cochrane Database Syst Rev. (12):CD000088.
- Pitschel-Walz G, Leucht S, Bauml J, Kissling W, Engel RR. 2001. The effect of family interventions on relapse and rehospitalization in schizophrenia–a meta-analysis. Schizophr Bull. 27(1):73–92. doi:https://doi.org/10.1093/oxfordjournals.schbul.a006861
- Quinn J, Barrowclough C, Tarrier N. 2003. The Family Questionnaire (FQ): a scale for measuring symptom appraisal in relatives of schizophrenic patients. Acta Psychiatr Scand. 108(4):290–296. doi:https://doi.org/10.1034/j.1600-0447.2003.00156.x
- Quirk A, Smith S, Hamilton S, Lamping D, Lelliott P, Stahl D, Pinfold V, Andiappan M. 2012. Development of the carer well‐being and support (CWS) questionnaire. Mental Health Review Journal. 17(3):128–138. doi:https://doi.org/10.1108/13619321211287184
- Ran MS, Chan CL, Ng SM, Guo LT, Xiang MZ. 2015. The effectiveness of psychoeducational family intervention for patients with schizophrenia in a 14-year follow-up study in a Chinese rural area. Psychol Med. 45(10):2197–2204. doi:https://doi.org/10.1017/S0033291715000197
- Sim J, Lewis M. 2012. The size of a pilot study for a clinical trial should be calculated in relation to considerations of precision and efficiency. J Clin Epidemiol. 65(3):301–308. doi:https://doi.org/10.1016/j.jclinepi.2011.07.011
- Spencer E, Birchwood M, McGovern D. 2001. Management of first-episode psychosis. Adv Psychiatr Treat. 7(2):133–140. doi:https://doi.org/10.1192/apt.7.2.133
- Spitzer RL, Kroenke K, Williams JB, Lowe B. 2006. A brief measure for assessing generalized anxiety disorder: the GAD-7. Arch Intern Med. 166(10):1092–1097. doi:https://doi.org/10.1001/archinte.166.10.1092
- Stanley S, Balakrishnan S, Ilangovan S. 2017. Psychological distress, perceived burden and quality of life in caregivers of persons with schizophrenia. J Ment Health. 26(2):134–141. doi:https://doi.org/10.1080/09638237.2016.1276537
- Szmukler GI, Burgess P, Herrman H, Benson A, Colusa S, Bloch S. 1996. Caring for relatives with serious mental illness: the development of the Experience of Caregiving Inventory. Soc Psychiatry Psychiatr Epidemiol. 31(3–4):137–148. doi:https://doi.org/10.1007/BF00785760
- Viana MC, Gruber MJ, Shahly V, Alhamzawi A, Alonso J, Andrade LH, Angermeyer MC, Benjet C, Bruffaerts R, Caldas-de-Almeida JM, et al. 2013. Family burden related to mental and physical disorders in the world: results from the WHO World Mental Health (WMH) surveys. Braz J Psychiatry. 35(2):115–125. doi:https://doi.org/10.1590/1516-4446-2012-0919
- Whiteford HA, Degenhardt L, Rehm J, Baxter AJ, Ferrari AJ, Erskine HE, Charlson FJ, Norman RE, Flaxman AD, Johns N, et al. 2013. Global burden of disease attributable to mental and substance use disorders: findings from the Global Burden of Disease Study 2010. Lancet. 382(9904):1575–1586. doi:https://doi.org/10.1016/S0140-6736(13)61611-6
- World Health Organization. 2017. Mental Health Atlas 2017. Geneva: WHO.